Onconetix, Inc.

US$6.95As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ONCOHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (96.91%)
Div yield —
ROE (105.23%)
Biotechnology
Beta (5Y) 2.62
PE TTM —
TSR TTM (99.59%)
Mkt cap US$2.745M
ROIC (33.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.06
1.53%
(87.82%)
Buy 1|2|3|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.12
0.11
0.12
5.26%
21.12%
18.03%
24.84%
Revenue$M
0.204
0.198
0.200
0.206
2.53%
1.55%
2.30%
0.43%
Peers (US$2.745M)
Cap (US$)
PE
2.990M
—
2.665M
—
Capital
TTM
5Y
10Y
Leveragex
1.564
0.145
0.121
EBIT/Intx
1.186
0.180
0.138
Own earn%
(45.59)
(280.91)
(225.78)
Sh yield%
16.04
45.34
46.99
Owners
Insiders/Inst%
7.00
75.85
Short interest%
4.34
SBC / revenue%
1.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–11
$1 testx
−0.3
Incr. ROIC%
14